Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal oxytocin effects on emotional and reward brain processes in PTSD
2012-001288-58Phase 2Completed
- Sponsor
- Academic Medical Center
- Start
- Mar 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of oxytocin in post-traumatic stress disorder (PTSD) (2 arms), sponsored by Academic Medical Center. Primary endpoints: Acute effects of intranasal oxytocin on emotional-related brain processes and Acute effects of intranasal oxytocin on reward-related brain processes. Started Mar 2012; status: completed.
02
Drugs
oxytocin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on 2012-001288-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001288-58.